Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;2(1):29.
doi: 10.1186/s40792-016-0156-3. Epub 2016 Mar 23.

Intrahepatic cholangiocarcinoma in a patient with Wilson's disease: a case report

Affiliations

Intrahepatic cholangiocarcinoma in a patient with Wilson's disease: a case report

Yosuke Mukai et al. Surg Case Rep. 2016 Dec.

Abstract

The incidence of hepatobiliary malignancies, and especially intrahepatic cholangiocarcinoma (ICC), for patients with Wilson's disease (WD), is very low, even for cirrhotic patients. A 44-year-old male was admitted to our department for treatment of a liver tumor. He was diagnosed with WD at the age of 15. According to radiological findings, his liver tumor was a suspected hepatocellular carcinoma (HCC) or a combined hepatocellular and cholangiocellular carcinoma. A partial resection of liver segments 8 (S8) and 5 (S5) was subsequently performed due to the intraoperative suspicion of intrahepatic metastasis at the surface of S5. Postoperative histology revealed that the resected portion of S8 contained an ICC; the removed S5 portion comprised a regenerative nodule with hemosiderosis. To date, the patient has survived without tumor recurrence for more than 44 months following surgery. A survey of the literature, inclusive of case reports, would suggest that surgical resection is the primary course of action for a WD patient with ICC, if liver function can be preserved and curative resection performed.

Keywords: Hepatobiliary malignancies; Intrahepatic cholangiocarcinoma; Liver tumor; Wilson’s disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Preoperative radiological findings. a Abdominal ultrasonography showed a hypoechoic lesion in segment 8 (S8) of the liver. b The main tumor (S8) showed an early enhancement in CT, which was prolonged until the delayed phase (c). d Gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-EDTA)-enhanced MRI revealed a solitary 1.8-cm tumor, with a low-intensity signal in the hepatobiliary phase in the transverse (d) and sagittal planes (e)
Fig. 2
Fig. 2
The resected specimens of S8 (a) and S5 (b). Histological examination of the resected specimens. c The lesion in S8 was a moderately differentiated cholangiocarcinoma of the liver (HE staining, ×100). The adjacent, non-cancerous liver parenchyma demonstrated typical cirrhotic features with steatosis (HE staining, ×40) (d), (HE staining, ×100) (e)

Similar articles

Cited by

References

    1. Xu R, Hajdu CH. Wilson disease and hepatocellular carcinoma. Gastroenterol Hepatol (N Y) 2008;4(6):438–9. - PMC - PubMed
    1. Pfeiffenberger J, Mogler C, Gotthardt DN, Schulze-Bergkamen H, Litwin T, Reuner U, et al. Hepatobiliary malignancies in Wilson disease. Liver Int. 2015;35(5):1615–22. doi: 10.1111/liv.12727. - DOI - PubMed
    1. Kamamoto Y, Makiura S, Sugihara S, Hiasa Y, Arai M. The inhibitory effect of copper on DL-ethionine carcinogenesis in rats. Cancer Res. 1973;33(5):1129–35. - PubMed
    1. Sternlieb I. Copper and the liver. Gastroenterology. 1980;78(6):1615–28. - PubMed
    1. Wilkinson ML, Portmann B, Williams R. Wilson’s disease and hepatocellular carcinoma: possible protective role of copper. Gut. 1983;24(8):767–71. doi: 10.1136/gut.24.8.767. - DOI - PMC - PubMed

LinkOut - more resources